Babies Fathered by Men on IBD Medications Aren’t at Higher Risk for Birth Problems, Study Finds

Babies Fathered by Men on IBD Medications Aren’t at Higher Risk for Birth Problems, Study Finds
Children whose fathers were exposed to drugs for the treatment of inflammatory bowel disease (IBD) -- primarily azathioprine (AZA) and 6-mercaptopurine (6-MP) -- within three months of conception had no significantly increased risk for adverse birth outcomes, according to the results of a large Danish national cohort study. The study, “Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study,” was published in the journal Gut. “This is the largest and most comprehensive study to date on t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *